44: Renal Function and Anesthesia

Published on 06/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1623 times

CHAPTER 44 Renal Function and Anesthesia

1 Describe the anatomy of the kidney

The kidneys are paired organs lying retroperitoneally against the posterior abdominal wall. Although their combined weight is only 300 g (about 0.5% of total body weight), they receive 20% to 25% of the total cardiac output. The renal arteries are branches of the aorta, originating below the superior mesenteric artery. The renal veins drain into the inferior vena cava. Nerve supply is abundant; sympathetic constrictor fibers are distributed via celiac and renal plexuses. There is no sympathetic dilator or parasympathetic innervation. Pain fibers, mainly from the renal pelvis and upper ureter, enter the spinal cord via splanchnic nerves.

On cross section of the kidney, three zones are apparent: cortex, outer medulla, and inner medulla (Figure 44-1). Eighty percent of renal blood flow is distributed to cortical structures. Each kidney contains about 1 million nephrons. Nephrons are classified as superficial (about 85%) or juxtamedullary, depending on location and length of the tubules. The origin of all nephrons is within the cortex.

The glomerulus and capsule are known collectively as the renal corpuscle. Each Bowman’s capsule is connected to a proximal tubule that is convoluted within its cortical extent but becomes straight limbed within the outer cortex; at this point the tubule is known as the loop of Henle. The loop of Henle of superficial nephrons descends only to the intermedullary junction, where it makes a hairpin turn, becomes thick limbed, and ascends back into the cortex, where it approaches and touches the glomerulus with a group of cells known as the juxtaglomerular apparatus. The superficial nephrons form distal convoluted tubules that merge to form collecting tubules within the cortex. The renal corpuscles of juxtamedullary nephrons are located at juxtamedullary cortical tissue. They have long loops of Henle that descend deep into the medullary tissue; the loops also reascend into cortical tissue, where they form distal convoluted tubules and collecting tubules. These nephrons (15% of the total) are responsible for conservation of water.

About 5000 tubules join to form collecting ducts. Ducts merge at minor calyces, which in turn merge to form major calyces. The major calyces join and form the renal pelvis, the most cephalic aspect of the ureter.

4 Review the site of action and significant effects of commonly used diuretics

See Table 44-1.

TABLE 44-1 Diuretics*

Drug (Example) Site of Action Action and Side Effects
Carbonic anhydrase inhibitors (acetazolamide) Proximal convoluted tubule Inhibits sodium resorption; interferes with H excretion; hyperchloremic, hypokalemic acidosis
Thiazides (hydrochlorothiazide) Cortical diluting segment (between ascending limb and aldosterone-responsive DCT) Inhibits sodium resorption; accelerates sodium-potassium exchange (hypokalemia); decreases GFR in volume-contracted states
Potassium-sparing diuretics (spironolactone, triamterene) Competitive inhibition of aldosterone in DCT Inhibiting aldosterone prevents sodium resorption and sodium-potassium exchange
Loop diuretics (furosemide, bumetanide, ethacrynic acid) Inhibit Cl resorption at thick ascending loop of Henle Potent diuretic; acts on critical urine-concentrating process; renal vasodilator; hypokalemia; can produce hypovolemia
Osmotic diuretics (mannitol, urea) Filtered at glomerulus but not resorbed; creates osmotic gradient in tubules; excretion of water and some sodium Hyperosmolality reduces cellular water; limited ability to excrete sodium; renal vasodilator

DCT, Distal convoluted tubule; GFR, glomerular filtration rate.

* With the exception of osmotic diuretics, all diuretics interfere with sodium conservation.

5 Describe the unique aspects of renal blood flow and control

Renal blood flow (RBF) of about 1200 ml/min is well maintained (autoregulated) at blood pressures of 80 to 180 mm Hg. The cortex requires about 80% of blood flow to achieve its excretory and regulatory functions, and the outer medulla receives 15%. The inner medulla receives a small percent of blood flow; a higher flow would wash out solutes responsible for the high tonicity (1200 mOsm/kg) of the inner medulla. Without this hypertonicity, urinary concentration would not be possible.

Control of RBF is through extrinsic and intrinsic neural and hormonal influences; a principal goal of blood flow regulation is to maintain GFR. The euvolemic, nonstressed state has little baseline sympathetic tone. Under mild-to-moderate stress RBF decreases slightly; but efferent arterioles constrict, maintaining GFR. During periods of severe stress (e.g., hemorrhage, hypoxia, major surgical procedures) both RBF and GFR decrease secondary to sympathetic stimulation.

The renin-angiotensin-aldosterone axis also has an effect on RBF. A proteolytic enzyme formed at the macula densa of the juxtaglomerular apparatus, renin acts on angiotensinogen within the circulation to produce angiotensin I. Enzymes within lung and plasma convert angiotensin I to angiotensin II, which is a potent renal vasoconstricting agent (especially of the efferent arteriole) and a factor in the release of aldosterone. During periods of stress levels of angiotensin are elevated and contribute (along with sympathetic stimulation and catecholamines) to decreased RBF.

Prostaglandins (PGs) are also found within the kidney. PGE2 and PGE3 are intrinsic mediators of blood flow, producing vasodilation.

10 Comment on various laboratory tests and their use in detecting acute renal dysfunction

Indices of renal function can be roughly divided into measures of glomerular or tubular function. Measures of clearance assess glomerular function, whereas the ability to concentrate urine and retain sodium are indices of tubular function. The majority of renal function tests are neither sensitive nor specific in predicting perioperative renal dysfunction and are affected by many variables common to the perioperative environment.

The ammonia generated from amino acid metabolism in the liver is converted to BUN. Urea is cleared rapidly by glomerular filtration but also resorbed in the tubules. Thus BUN cannot be used as a marker of glomerular filtration, only azotemia. Creatinine is the end product of creatinine phosphate metabolism and is generated from muscle and handled by the kidney in a relatively uniform fashion. Dietary meat is also a source of creatinine. Serum creatinine (Scr) is a function of muscle mass and such factors of activity, diet, and hemodilution alter its serum concentration. Scr can be artifactually increased by barbiturates or cephalosporins. Additional nonrenal variables may also be responsible for elevation of BUN and creatinine, including increased nitrogen absorption, muscle trauma from burns or injury, hypercatabolism, hepatic disease, diabetic ketoacidosis, hematoma resorption, gastrointestinal bleeding, hyperalimentation, and many drugs (e.g., steroids). The usual ration of BUN to creatinine is 10:1, and a ratio greater than 20:1 implies a prerenal syndrome.

Elevation of Scr is a late sign of renal dysfunction. The relationship between Scr and GFR is inverse and exponential. That is to say, a doubling of Scr reflects halving the GRF. This is of greater clinical significance at lower levels of creatinine; an increase of creatinine from 4 to 8 mg/dl does not represent a large absolute decrease in GFR because GFR is already remarkably diminished at 4 mg/dl.

When renal function is stable, using nomograms, creatinine is a reasonable measure of GFR. However, Scr measurements are inaccurate when GFR is rapidly changing. GFR may be reduced by 50% or more before abnormal elevation is observed. Because creatinine production is proportionate to muscle mass, in situations in which substantial wasting has already occurred (e.g., chronic illness, advanced age) creatinine levels may be normal despite markedly reduced GFR.

GFR declines with age. A healthy individual of age 20 has a GFR of about 125 ml/min; an otherwise healthy patient at age 60 has a GFR about 60 ml/min. Scr does not begin to increase until GFR falls to about 50 ml/min. GFR can be estimated using population studies based on the patient’s age, Scr, sex, and weight. The method of Cockroft and Gault uses the following formula for estimating GFR: GFR = (140 – age) × weight (kg)/(Scr × 72). This is the formula for male, and the result is multiplied by 0.85 to determine the GFR for females. It is obvious that this overestimates GFR in obese patients when total body weight, not ideal body weight, is used. This formula may also overestimate GFR in cachectic patients in whom creatinine production is low.

Creatinine clearance (Ccr) is a sensitive test of renal function. Creatinine is filtered at the glomerulus and not resorbed. There is also some secretion of creatinine with the tubules, and this results in about a 15% overestimation of Ccr. (In actuality, clearance of inulin, a polyfructose sugar, is the gold standard for measurement of GFR because it is filtered at the glomerulus and neither resorbed nor secreted at the tubules.) It has been a long held belief that measurement of Ccr required 12- to 24-hour urine collections. In fact, if Scr is rapidly changing, calculations of Ccr based on 24 hours of urine collection and a single creatinine measurement may be inaccurate. In addition, this method requires meticulous urine collection, and failure to accomplish this is a common source of laboratory error. Two-hour spot tests are thought to be reasonably accurate, and serial 2-hour spot tests may be particularly valuable when renal function is acutely deteriorating. Table 44-2 describes various tests of renal function.

18 How are patients with renal insufficiency managed perioperatively?

Preoperative preparation is of benefit for patients with end-stage renal disease (ESRD), who have up to a 20% mortality for emergent surgical procedures. Primary causes of death include sepsis, dysrhythmias, and cardiac dysfunction. Hemodynamic instability is common. From the standpoint of renal dysfunction, there may be a decreased ability to concentrate urine, decreased ability to regulate extracellular fluid and sodium, impaired handling of acid loads, hyperkalemia, and impaired excretion of medications. Renal impairment is confounded by anemia, uremic platelet dysfunction, arrhythmias, pericardial effusions, myocardial dysfunction, chronic hypertension, neuropathies, malnutrition, and susceptibility to infection. Nephrotoxic agents (e.g., amphotericin, nonsteroidal antiinflammatory drugs, aminoglycosides) should be avoided. If a radiocontrast is contemplated, the real value of the test should be considered. If the contrast study is definitely indicated, the patient should be well hydrated, and the contrast dose limited to the minimum needed.

Medications commonly used perioperatively may have increased effects in patients with chronic renal insufficiency. Because these patients are hypoalbuminemic, medications that are usually protein bound such as barbiturates and benzodiazepines may have increased serum levels. Both morphine and meperidine have metabolites that are excreted by the kidney. Succinylcholine increases extracellular potassium but can be used if serum potassium is normal. Hyperkalemia should be considered in patients with ESRD who develop ventricular arrhythmias or cardiac arrest. Rapid administration of calcium chloride temporizes the cardiac effects of hyperkalemia until further measures (administration of insulin and glucose, hyperventilation, administration of sodium bicarbonate and potassium-binding resins, and dialysis) can be taken to shift potassium intracellularly and decrease total body potassium.

Before surgery patients must be euvolemic, normotensive, normonatremic, normokalemic, not acidotic or severely anemic, and without significant platelet dysfunction. Ideally they should have had dialysis the day of or day before surgery. Dialysis usually corrects uremic platelet dysfunction and is best performed within the 24 hours before surgery, although 1-deamino-8-d-arginine vasopressin (DDAVP) may also be administered if bleeding is persistent. Other indications for acute dialysis include uremic symptoms, pericardial tamponade, bleeding, hypervolemia, congestive heart failure, hyperkalemia, and severe acidosis.

Patients with ESRD who have left ventricular dysfunction or undergo major procedures with significant fluid shifts require invasive monitoring to guide fluid therapy. A sterile technique should be strictly followed when inserting any catheters. In minor procedures fluids should be limited to replacement of urine and insensible losses. Normal saline is the fluid of choice as it is free of potassium. However, if large fluid requirements are necessary, normal saline administration may result in hyperchloremic metabolic acidosis. Clearly cases of this magnitude require invasive monitoring and repeated laboratory analysis.